{
    "2018-12-22": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Genome Sequencing Stocks to Buy for Healthy Gains",
                "features": {
                    "keywords": [
                        "Genome",
                        "Sequencing",
                        "Buy",
                        "Healthy Gains"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Merck KGaA & Pfizer Decide To Discontinue JAVELIN Ovarian 100 Study Of Avelumab",
                "features": {
                    "keywords": [
                        "Merck KGaA",
                        "Pfizer",
                        "Discontinue",
                        "JAVELIN",
                        "Ovarian",
                        "Avelumab"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}